184 related articles for article (PubMed ID: 999252)
1. [Rate of tetracycline dissolution from tablets and capsules and the biological availability of the antibiotic].
Okhotnikova VF; Grakovskaia LK; Koroleva VG; Minasova GS; Zak IR
Antibiotiki; 1976 Aug; 21(8):719-21. PubMed ID: 999252
[TBL] [Abstract][Full Text] [Related]
2. [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals].
Zak AF; Ermolova OB
Antibiotiki; 1976 Feb; 21(2):151-5. PubMed ID: 1275466
[TBL] [Abstract][Full Text] [Related]
3. [Effect of auxiliary substances on the bioavailability of tetracycline hydrochloride capsules (an in vitro study)].
Grakovskaia LK; Nesterova LIa; Okhotnikova VF; Zak AF; Ermolova OB
Antibiotiki; 1978 Mar; 23(3):215-9. PubMed ID: 637528
[TBL] [Abstract][Full Text] [Related]
4. [Bioavailability of tetracycline hydrochloride capsules (an in vivo study)].
Zak AF; Ermolova OB; Batuashvili TA; Minasova GS; Nesterova LIa
Antibiotiki; 1978 May; 23(5):441-5. PubMed ID: 350144
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
Breier AR; Paim CS; Steppe M; Schapoval EE
J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
[TBL] [Abstract][Full Text] [Related]
6. [Bioavailability of ampicillin preparations for internal use].
Zak AF; Batuashvili TA; Shchedrin VI
Antibiotiki; 1980 Jan; 25(1):24-8. PubMed ID: 7356297
[TBL] [Abstract][Full Text] [Related]
7. [Effect of the tetracycline base crystallization conditions on the properties of the powders and drug forms obtained. Relationship between the dispersity of the tetracycline powder and the biological availability in capsules].
Lin'kov GI; Okhotnikova VF; Koroleva VG; Nabokov VS; Zhuskovskaia SA
Antibiotiki; 1978 Feb; 23(2):174-8. PubMed ID: 629528
[No Abstract] [Full Text] [Related]
8. [Bioavailability of peroral drug forms of oxacillin].
Batuashvili TA; Shchedrin VI; Zak AF
Antibiotiki; 1979 Aug; 24(8):611-5. PubMed ID: 485110
[TBL] [Abstract][Full Text] [Related]
9. Choice of rotation speed (rpm) for bio-relevant drug dissolution testing using a crescent-shaped spindle.
Qureshi SA
Eur J Pharm Sci; 2004 Nov; 23(3):271-5. PubMed ID: 15489128
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers.
Leucuţa SE; Vida-Simiti L; Căprioară MG; Făgărăşan E; Olinic N; Manasia M; Vlaicu R
Pharmazie; 1989 May; 44(5):336-8. PubMed ID: 2772014
[TBL] [Abstract][Full Text] [Related]
11. [Bioavailability of drug forms of tetracycline-group semisynthetic preparations for internal use].
Zak AF; Batuashvili TA
Antibiotiki; 1983 Sep; 28(9):659-63. PubMed ID: 6638980
[TBL] [Abstract][Full Text] [Related]
12. [Properties of tetracycline hydrochloride tablets and their bioavailability].
Zak AF; Batuashvili TA; Loseva GI; Shatrova VM; Ermolova OB
Antibiotiki; 1980 Mar; 25(3):179-84. PubMed ID: 7362222
[TBL] [Abstract][Full Text] [Related]
13. [Dissolution determination in the rotating flask model. Effect of rotation rate and fluid volume on the solubility determination of standard test tablets in the Resotest dissolution tester].
Koch HP; Pfeifer G
Pharmazie; 1983 May; 38(5):318-23. PubMed ID: 6611628
[TBL] [Abstract][Full Text] [Related]
14. [Bioavailability of levomycetin preparations for oral use].
Batuashvili TA; Zak AF
Antibiotiki; 1983 Oct; 28(10):751-4. PubMed ID: 6651263
[TBL] [Abstract][Full Text] [Related]
15. [Comparative evaluation of methacycline hydrochloride capsules and tablets according to their dissolubility and rate of solution].
Berezovskaia LN; Grakovskaia LK; Nesterova LIa
Antibiotiki; 1979 Aug; 24(8):604-8. PubMed ID: 485108
[TBL] [Abstract][Full Text] [Related]
16. Automated dissolution test for tablets and capsules.
Randall N; Goldsmith JA
Lab Pract; 1975 Feb; 24(2):77-8. PubMed ID: 1134048
[No Abstract] [Full Text] [Related]
17. Pharmaceutical availability from oral dosage forms: in vitro release of nitrofurantoin from tablets and capsules.
Senjković R; Kallay N; Vilendecić M
Pharmazie; 1987 Mar; 42(3):186-8. PubMed ID: 3602077
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
Khan MK; Khan MF; Khan H; Mustafa G
Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of nalidixic acid from uncoated tablets in humans--Part I: Correlation with the dissolution rates of the tablets.
Ogata H; Aoyagi N; Kaniwa K; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):175-83. PubMed ID: 6715086
[TBL] [Abstract][Full Text] [Related]
20. The pharmaceutical and biological availability of commercial preparations of furosemide.
Stüber W; Mutschler E; Steinbach D
Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
